https://www.selleckchem.com/pr....oducts/Ubenimex(Best
Hospitalized patients with COVID-19have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking. To assess the incidence of and risk factors for thrombosis in hospitalized patients with cancer and COVID-19. Among patients with cancer in the COVID-19 and Cancer Consortium registry (CCC19) cohort study, we assessed the incidence of VTE and ATE within 9